XULTOPHY
XULTOPHY
Approved
DIN Number
02474875
Drug Class
Human
Market Date
Jun 6, 2018
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02474875
AIG Number0260170001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A10AE56 INSULIN DEGLUDEC AND LIRAGLUTIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (2)
INSULIN DEGLUDECActive
Strength: 100 UNIT / ML
Monograph: INSULIN DEGLUDEC
LIRAGLUTIDEActive
Strength: 3.6 MG / ML
Monograph: LIRAGLUTIDE